Pentracor GmbH

Industry · 3 registered clinical trials.

Status	Trial	Phase	Started
Withdrawn	CRP-Apheresis for Attenuation of Pulmonary, MYocardial and/or Kidney Injury in COvid-19 Covid19	N/A	2021-05-05
Terminated	CASTRO1 - Study on CRP Apheresis After Ischemic Stroke Stroke, Ischemic	N/A	2021-01-28
Completed	Study on CRP Apheresis After Coronary Bypass Surgery Post-cardiac Surgery	N/A	2018-03-21